Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2209 of 5804
-
New telehealth program aims to help autistic kids with bowel accidents
Disease control Recruiting nowThe current study aims to monitor fecal continence after autistic youth complete enuresis treatment and for individuals who continue to experience encopresis after acquiring urine continence, evaluate a caregiver-mediated version of a Multidisciplinary Intervention for Encopresis…
Phase: PHASE4 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could an old antibiotic boost prostate cancer treatment?
Disease control Not yet recruitingThe researchers hope to learn if Trimethoprim, 150mg taken daily for 3 months, is a safe and effective way to reduce folate levels at time of Androgen Deprivation Therapy (ADT) in men with advanced prostate cancer. This study will help find out what effects, good and/or bad, thi…
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New implant study aims to restore smiles for those with severe jaw bone loss
Disease control Not yet recruitingThe goal of this prospective study is to assess short term (12-months) clinical outcomes of NobelZygoma TiUltra implants and Multi-unit Abutment Xeal in the rehabilitation of participants with severely atrophic maxilla treated with zygomatic dental implant procedure. The main goa…
Phase: NA • Sponsor: Nobel Biocare • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Foot reflexology may soothe chemo nausea in breast cancer patients
Symptom relief Not yet recruitingThis study aims to evaluate the effect of foot reflexology on chemotherapy-induced nausea and vomiting in breast cancer patients. Nausea and vomiting are common side effects of chemotherapy and can negatively affect patients' comfort and quality of life. Foot reflexology is a non…
Phase: NA • Sponsor: University of Health Sciences Lahore • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
Can magic mushrooms boost brain health in seniors?
Knowledge-focused Recruiting nowThis study is being conducted to understand changes in brain activity following administration of two different drugs (Psilocybin and Dextromethorphan) in older adults with low well-being. The main questions it aims to answer are, does psilocybin: 1. Acutely increase complexity…
Phase: PHASE1 • Sponsor: Jennifer Mitchell • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Promising drug aims to slow kidney damage in rare lowe syndrome
Disease control Not yet recruitingThe primary objective of this trial is to: 1\. Evaluate the efficacy of piclidenoson to increase renal uptake of 99mTc-labeled DMSA, in comparison to baseline, after 6 months (26 weeks) of treatment as a measure the reabsorption capacity of LMWPs by renal proximal tubules. The …
Phase: PHASE2 • Sponsor: Can-Fite BioPharma • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can a tiny eye implant tame chronic uveitis Flare-Ups?
Disease control Not yet recruitingNon-infectious posterior uveitis is a chronic inflammatory eye disease that can lead to irreversible retinal damage and visual impairment due to repeated inflammatory relapses. The fluocinolone acetonide intravitreal implant is approved for the prevention of inflammatory relapse…
Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Sugar water shots may ease back pain in Bendy-Bodied patients
Symptom relief Not yet recruiting1. Specific Aim: To show the safety and efficacy of prolotherapy injection for chronic sacroiliac and myofascial lumbar pain while standardizing an ultrasound guided injection technique 2. Specific Aim: To demonstrate that dextrose prolotherapy subjectively decreases lumbar back …
Phase: PHASE3 • Sponsor: Tulane University • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Smartwatch data could ease cancer symptoms in new study
Symptom relief Not yet recruitingBeacon is a digital platform that processes objective and subjective aggregated data provided by patients. Objective data is provided by standard wearables, while subjective data is provided by patient-reported outcome measures (PROMs), comprising written and vocal patient report…
Phase: NA • Sponsor: Tzeela Cohen • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Two-Hour zoom class aims to ease cancer pain
Symptom relief Recruiting nowThis randomized controlled study to examine the efficacy of ER class in cancer survivors with chronic pain. Eligible participants will be randomly assigned to a ER class or a waitlist control condition. We will recruit 250 participants with a goal of having 200 completers (20% at…
Phase: NA • Sponsor: University of Oklahoma • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Psoriasis drug showdown: which pill works better?
Disease control Not yet recruitingThis randomized controlled trial aims to compare the efficacy and safety of oral methotrexate and tofacitinib in patients with chronic plaque psoriasis. Participants diagnosed with chronic plaque psoriasis will be randomly assigned to receive either methotrexate or tofacitinib an…
Phase: NA • Sponsor: Pak Emirates Military Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New PET scan method aims to outsmart brain tumor comebacks
Diagnosis Not yet recruitingThis is a retrospective study encompassing all \[18F\]FET PET scans performed at our centre. By analysing both static and dynamic scans, conducting in-depth kinetic modelling, and comparing quantitative parameters across different tumour types and clinical contexts, the study aim…
Sponsor: IRCCS San Raffaele • Aim: Diagnosis
Last updated Jun 27, 2026 12:36 UTC
-
Could a pre-treatment boost t-cell power against myeloma?
Disease control Recruiting nowThis is a single center, single arm Phase Ib study with expansion cohort designed to establish the safety and physiologic effects of sirolimus pre-conditioning followed by T-cell engaging bispecific antibody therapy.
Phase: PHASE1 • Sponsor: Christopher Strouse • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New pill aims to slow kidney disease in IgA nephropathy patients
Disease control Not yet recruitingThis is a multicenter, randomized, double-blind, placebo controlled Phase IIb study to explore the efficacy and safety of STL303 capsules in IgAN patients. About 15 patients dignosed with primary IgAN will be enrolled and randomized to three cohorts and take different dosage of S…
Phase: PHASE2 • Sponsor: Sitala Bio LTD • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Your DNA may push you to get that first colonoscopy
Knowledge-focused ENROLLING_BY_INVITATIONThe goal of this study is to investigate genetic risk for colorectal cancer utilizing polygenic risk scores (PRS) for adults over 45 who have not received their first colonoscopy. The main questions it hopes to address are: 1. How does knowledge of a patient's genetic risk for c…
Sponsor: Endeavor Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Brown fat may hold key to weight loss drug response
Knowledge-focused Not yet recruitingThis study investigates whether the activity of brown adipose tissue (BAT) - a special type of fat that burns energy as heat - can predict how well individuals with obesity respond to semaglutide (Wegovy), a once-weekly injectable weight loss medication. Participants who are star…
Phase: NA • Sponsor: Hallym University • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
New drug SHR-5421 takes on Hard-to-Treat multiple myeloma
Disease control Not yet recruitingThis is a Phase I, open-label, multicenter study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of SHR-5421 in patients with multiple myeloma (MM).
Phase: PHASE1 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a stomach shield drug replace acid blockers for steroid users?
Disease control Not yet recruitingObjective: To evaluate the efficacy, safety, and adherence of the gastric mucosal protective agent teprenone in the treatment of glucocorticoid-induced drug-related gastrointestinal injury. Study Design: This study is a prospective, open-label, randomized controlled trial. The…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Social coaching may ease anxiety and autism traits in rare chromosome conditions
Symptom relief Recruiting nowWe will examine is Social Management Training, a 10-session group-based psychosocial intervention will improve the primary outcome mental health, and secondary outcomes executive functions and autism symptoms, in a multiple baseline design with 3 pre-measurement points and 3 post…
Phase: PHASE1 • Sponsor: University of Oslo • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Ancient breathing techniques put to the test for COPD relief
Symptom relief Not yet recruitingCOPD is a common respiratory disease characterized by progressive airflow obstruction, dyspnea, chronic cough, and sputum production. Alternate nostril breathing and bellows breath are pranayama-based breathing techniques that may improve respiratory function and overall well-bei…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC